Back to search
FDAFDA · Food and drugs·Recall number D-128-2013

CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88

Published January 23, 2013 · Recall initiated: April 24, 2012

Summary

FDA records drug Class III recall D-128-2013, published January 23, 2013 and initiated April 24, 2012. Recalling firm: Teva Pharmaceuticals USA, Inc.; Status: Terminated; Reported quantity: 13,232 bottles; Lot: Lot number 6A007046V, exp 07/12. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life

What to do

Voluntary: Firm initiated · Letter

Get an email if CABERGOLINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CABERGOLINE
Manufacturer
Teva Pharmaceuticals USA, Inc.
Distributor
Nationwide
Lot
Lot number 6A007046V, exp 07/12
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88 recalled?

Yes. FDA published recall D-128-2013 on January 23, 2013. Reported hazard: Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CABERGOLINE.